Mastering Novel Food Production
Event description
The novel food sector is at a pivotal moment. While cell-cultivated foods and precision fermentation promise a more sustainable, resilient protein supply, the path from R&D to commercial production demands more than bigger bioreactors. Success at scale requires consistent quality, tight process control, and data-driven optimization under real-world conditions.
That’s where Process Analytical Technology (PAT) comes in. By enabling real-time monitoring and control, PAT helps teams improve efficiency, reduce costs, and shorten time to market.
On September 25, Hamilton Process Analytics will convene a panel of experts from cell cultivation and precision fermentation for Mastering Novel Food Production—a dynamic discussion of why PAT is central to unlocking the next phase of growth for the industry. GFI’s Elliot Swartz, Ph.D. (principal scientist, cultivated meat) will contribute insights on measurement needs across the cultivated meat value chain, from cell line development to bioprocess optimization and product quality attributes.
Whether you’re in R&D, scale-up, or manufacturing, you’ll come away with practical perspectives on:
- Prioritizing critical quality attributes and inline/online measurements
- Translating lab methods to robust, GMP-ready workflows
- Reducing batch variability and improving cost of goods with smarter controls
- Building cross-functional teams that unite science, engineering, and analytics
We hope you’ll join us for this timely conversation. Register at the link above.
GFI speaker

Elliot Swartz, Ph.D.
SENIOR PRINCIPAL SCIENTIST, CULTIVATED MEAT
Elliot’s work at GFI focuses on analyzing the technical and economic bottlenecks facing the cultivated meat industry, identifying opportunities to accelerate the industry, and educating scientists, the public, and other industry stakeholders. For the past five years, Elliot has worked on projects ranging from food safety and environmental impact to in-depth analysis of the cultivated meat value chain. Elliot holds a Ph.D. in neuroscience from the University of California, Los Angeles (UCLA), where he worked with induced pluripotent stem cells to model neuromuscular disease.